Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPRING: Tipranavir/ritonavir in HIV+
NCT00440271Phase 3Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of tipranavir in human immunodeficiency virus infection (HIV), sponsored by Boehringer Ingelheim. Started Feb 2007; status: terminated.
02
Drugs
tipranavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00440271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00440271.